Immunotherapy Research Center (면역치료제연구센터)
Results 1-20 of 59 (Search time: 0.005 seconds).
No. | Year | Title | Type |
---|---|---|---|
59 | 2022 | 2022Research Project 지질기반 후보물질을 이용한 항종양/항염증 효과를 갖는 신약 개발 선도 물질 발굴연구책임자 : 김재화 / 사업기간 : 2022.02.01 ~ 2023.01.31 |
Research Project |
58 | 2022 | 2022Research Project 항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2022.01.01 ~ 2022.12.31 |
Research Project |
57 | 2022 | 2022Research Project 종양미세환경에서 KLK6의 암 전이 조절 기전 규명 및 치료 타겟 유효성 검증 = Study on the mechanism of cancer metastasis and validation as therapeutic target of KLK6 in tumor microenvironment연구책임자 : 조희준 / 사업기간 : 2022.03.01 ~ 2023.02.28 |
Research Project |
56 | 2022 | 2022Research Project 신경전달물질 검출 기기 및 우울증 모니터링 기술 개발 = Development of neurotransmitter detection device and depression monitoring technology연구책임자 : 권오석 / 사업기간 : 2022.06.01 ~ 2023.05.31 |
Research Project |
55 | 2021 | 2021Patent 신규한 IL-15-IL-21 융합 폴리펩티드 및 이의 용도KR10-2018-0142650 (2018.11.19) / 10-2255964 (2021.05.18)이희구; 최인표; 조희준; 김보연 |
Patent |
54 | 2021 | 2021Article Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calcium-mediated cell signalingOncology Reports, vol. 45, no. 4, pp. 6-6Sang Yoon Park; Jong-Tae Kim; Eun Sun Park; Yo Sep Hwang; Hyang Ran Yoon; Kyung Eun Baek; Haiyoung Jung; Suk Ran Yoon; Bo Yeon Kim; Hee Jun Cho, et al. |
Article |
53 | 2021 | 2021Research Project 항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
52 | 2021 | 2021Research Project 종양미세환경에서 KLK6의 암 전이 조절 기전 규명 및 치료 타겟 유효성 검증 = Study on the mechanism of cancer metastasis and validation as therapeutic target of KLK6 in tumor microenvironment연구책임자 : 조희준 / 사업기간 : 2021.03.01 ~ 2022.02.28 |
Research Project |
51 | 2021 | 2021Research Project 악액질 조절인자 발굴 및 면역제어 기술 개발연구책임자 : 이희구 / 사업기간 : 2021.09.01 ~ 2022.08.31 |
Research Project |
50 | 2020 | 2020Article Cullin 3/KCTD5 promotes the ubiqutination of Rho guanine nucleotide dissociation inhibitor 1 and regulates its stabilityJournal of Microbiology and Biotechnology, vol. 30, no. 10, pp. 1488-1494Hee Jun Cho; K J Ryu; Kyoung Eun Baek; Jeewon Lim; T Kim; C Y Song; J Yoo; Hee Gu Lee |
Article |
49 | 2020 | 2020Article TXNIP regulates natural killer cell-mediated innate immunity by inhibiting IFN-γ production during bacterial infectionInternational Journal of Molecular Sciences, vol. 21, no. 24, pp. 9499-9499D O Kim; Jae Eun Byun; Won Sam Kim; M J Kim; Jung Ha Choi; Hanna Kim; Eunji Choi; Tae-Don Kim; Suk Ran Yoon; Ji Yoon Noh, et al. |
Article |
48 | 2020 | 2020Article Dysregulation of Rho GTPases in human cancersCancers, vol. 12, no. 5, pp. 1179-1179Haiyoung Jung; Suk Ran Yoon; Jeewon Lim; Hee Jun Cho; Hee Gu Lee |
Article |
47 | 2020 | 2020Article Regulation of hematopoietic stem cell fate and malignancyInternational Journal of Molecular Sciences, vol. 21, no. 13, pp. 4780-4780Hee Jun Cho; Jungwoon Lee; Suk Ran Yoon; Hee Gu Lee; Haiyoung Jung |
Article |
46 | 2020 | 2020Research Project 항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2020.01.01 ~ 2020.12.31 |
Research Project |
45 | 2020 | 2020Research Project 에피프로테옴 기반 발암 및 암전이 치료 신규 원천기술 개발연구책임자 : 김보연 / 사업기간 : 2020.07.01 ~ 2021.06.30 |
Research Project |
44 | 2020 | 2020Research Project RhoGDI1 결합단백질들의 기능분석을 통한 암 전이 기전 연구 = Study on the regulation mechanism of cancer metastasis through the functional analysis of RhoGDI1 interacting proteins연구책임자 : 조희준 / 사업기간 : 2020.03.01 ~ 2021.02.28 |
Research Project |
43 | 2019 | Patent | |
42 | 2019 | Report | |
41 | 2019 | 2019Article Morin hydrate reverses cisplatin resistance by impairing PARP1/HMGB1-dependent autophagy in hepatocellular carcinomaCancers, vol. 11, pp. 986-986M P Singh; Hee Jun Cho; Jong-Tae Kim; Kyoung Eun Baek; Hee Gu Lee; S C Kang |
Article |
40 | 2019 | 2019Article p38 stabilizes snail by suppressing DYRK2-mediated phosphorylation that is required for GSK3β-βTrCP-induced snail degradationCancer Research, vol. 79, no. 16, pp. 4135-4148K J Ryu; S M Park; Seung-Ho Park; I K Kim; H Han; H J Kim; S H Kim; K S Hong; H Kim; M Kim, et al. |
Article |